RxDoctor Payments Data

Ahmed Khan, MD

Hospitalist · Milwaukee, WINPI 1780017749

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 38.0% of the total. Reporting peaked in 2024 at $212 and has fallen 93.3% since, to $14 in 2025. Among hospitalist clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$774in general payments, 2019–2025

Across 45 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$294
  • Shire North American Group Inc$145
  • Johnson & Johnson$118
  • Merck$49
  • Gilead$47
  • Vifor Pharma, Inc.$27
  • plus $93 from 5 others

What the payments were for

  • Food & beverage$774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$774 in reported general payments places this provider in the 90th percentile of 679 hospitalist providers in Wisconsin.

See all hospitalist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$72,955
Medicare patients
308
Services billed
538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium12$120

Paid to pharmacies, not to this prescriber.

Other hospitalist in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →